Oculus Advisors advised a family office on its growth capital investment in RenovoRX, a medical device and drug company headquartered in Silicon Valley. RenovoRX is in Phase III trials for a proprietary treatment platform, initially targeting pancreatic cancer
Oculus Advisors is an investor in RenovoRX
Sponsor: Family Office and Oculus Advisors
In August 2021, Oculus Advisors invested alongside management in VideoTaxi, an industry-leading, independent producer of video content...
$US10 million senior secured loan facility into an Australian subsidiary of Trident Royalties Plc, a UK-listed entity that owns a number...
A consortium comprising STAR Capital, 3i Infrastructure and Morgan Stanley Infrastructure acquired Eversholt, one of the three largest...
Comments